| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |